Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|January 1, 1986
Dopaminergic control of aldosterone secretion in hypertensive patients chronically treated with an angiotensin converting enzyme inhibitorB Waeber, J Nussberger, M D Schaller, et al.Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|October 1, 1983
Long-term clinical experience with enalapril in essential hypertensionH R Brunner, B Waeber, J Nussberger, et al.British Journal of Clinical Pharmacology|February 1, 1989
The pharmacokinetics of lisinopril in hospitalized patients with congestive heart failureA E Till, K Dickstein, T Aarsland, et al.International Journal of Cardiology|April 1, 1986
Enalapril in congestive heart failure: acute and chronic invasive hemodynamic evaluationH J Gomez, V J Cirillo, R O Davies, et al.Biopharmaceutics & Drug Disposition|July 1, 1989
Pharmacokinetics of lisinopril (IV/PO) in healthy volunteersB Beermann, A E Till, H J Gomez, et al.Lancet (London, England)|November 29, 1986
Haemodynamic effects of atrial peptide infusion in heart failureI G Crozier, M G Nicholls, H Ikram, et al.Clinical Pharmacology and Therapeutics|June 1, 1987
Pharmacokinetics of synthetic atrial natriuretic peptides in normal menJ Biollaz, L T Callahan, J Nussberger, et al.Journal of Pharmacokinetics and Biopharmaceutics|December 1, 1982
Pharmacokinetics of the pivaloyloxyethyl (POE) ester of methyldopa, a new prodrug of methyldopaM R Dobrinska, W Kukovetz, E Beubler, et al.Kidney International|October 1, 1987
Site of the action of a synthetic atrial natriuretic peptide evaluated in humansJ Biollaz, J Bidiville, J Diézi, et al.British Journal of Clinical Pharmacology|May 1, 1988
Lisinopril: dose-peak effect relationship in essential hypertensionV J Cirillo, H J Gomez, J Salonen, et al.Pageof 4